Literature DB >> 24646182

Comparison of therapeutic efficacy and safety of radiofrequency ablation of hepatocellular carcinomas between internally cooled 15-G and 17-G single electrodes.

H J Park, M W Lee, K D Song, D I Cha, H Rhim, T W Kang, S Lim, H K Lim.   

Abstract

OBJECTIVE: To compare the ablation volume, local tumour progression rate and complication rate of radiofrequency ablation (RFA) for small hepatocellular carcinomas (HCCs) using 15-G and 17-G single electrodes.
METHODS: This retrospective study was approved by the institutional review board and informed consent was waived. We reviewed percutaneous RFA cases for HCCs using 15-G or 17-G electrodes without multiple overlapping ablations. A total of 36 pairs of HCCs matched according to tumour size and active tip length were included. We compared ablation volume and complication rate between the two electrode groups. Cumulative local tumour progression rates were estimated using the Kaplan–Meier method and compared using the log-rank test.
RESULTS: Tumour size and ablation time were not significantly different between the 15-G and 17-G groups (p50.661 and p50.793, respectively). However, ablation volume in the 15-G electrode group was larger than that in the 17-G group (14.465.4cm3 vs 8.762.5cm3; p,0.001). No statistical difference in complication rates between the two electrode groups was found. The 10- and 20-month local tumour progression rates were not significantly different between the two groups (2.8% and 5.6% vs 11.1% and 19.3%; p50.166).
CONCLUSION: Ablation volume by the 15-G electrode was larger than that by the 17-G electrode. However, local tumour progression rate and complication rate were not significantly different between the two electrode groups. ADVANCES IN KNOWLEDGE: RFA of HCC using a 15-G electrode is useful to create larger ablation volumes than a 17-G electrode.

Entities:  

Mesh:

Year:  2014        PMID: 24646182      PMCID: PMC4067013          DOI: 10.1259/bjr.20130534

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

2.  Multiple-electrode radiofrequency ablations using Octopus® electrodes in an in vivo porcine liver model.

Authors:  E S Lee; J M Lee; W S Kim; S H Choi; I Joo; M Kim; D H Yoo; R-E Yoo; J K Han; B I Choi
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

3.  Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.

Authors:  Min Woo Lee; Hyunchul Rhim; Dong Ik Cha; Young Jun Kim; Dongil Choi; Young-sun Kim; Hyo K Lim
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

Review 4.  Image-guided tumor ablation: standardization of terminology and reporting criteria.

Authors:  S Nahum Goldberg; Clement J Grassi; John F Cardella; J William Charboneau; Gerald D Dodd; Damian E Dupuy; Debra Gervais; Alice R Gillams; Robert A Kane; Fred T Lee; Tito Livraghi; John McGahan; David A Phillips; Hyunchul Rhim; Stuart G Silverman
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

5.  Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems.

Authors:  Alban L Denys; Thierry De Baere; Viseth Kuoch; Benoit Dupas; Patrick Chevallier; David C Madoff; Pierre Schnyder; Francesco Doenz
Journal:  Eur Radiol       Date:  2003-08-27       Impact factor: 5.315

6.  A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.

Authors:  Min Jung Park; Young-sun Kim; Hyunchul Rhim; Hyo Keun Lim; Min Woo Lee; Dongil Choi
Journal:  J Vasc Interv Radiol       Date:  2011-06       Impact factor: 3.464

7.  Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.

Authors:  Young-sun Kim; Hyo Keun Lim; Hyunchul Rhim; Min Woo Lee; Dongil Choi; Won Jae Lee; Seung Woon Paik; Kwang Cheol Koh; Joon Hyeok Lee; Moon Seok Choi; Geum-Youn Gwak; Byung Chul Yoo
Journal:  J Hepatol       Date:  2012-09-27       Impact factor: 25.083

Review 8.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Radiofrequency ablation of hepatocellular carcinoma: a literature review.

Authors:  Yasunori Minami; Masatoshi Kudo
Journal:  Int J Hepatol       Date:  2011-05-11
View more
  3 in total

1.  Hepatic radiofrequency ablation: in vivo and ex vivo comparisons of 15-gauge (G) and 17-G internally cooled electrodes.

Authors:  K D Song; M W Lee; H J Park; D I Cha; T W Kang; J Lee; J Y Moon; H Rhim
Journal:  Br J Radiol       Date:  2015-04-17       Impact factor: 3.039

Review 2.  Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: Case report and literature review.

Authors:  Min-Woo Chung; Sang-Yoon Ha; Jung-Ho Choi; Hyuk-Jin Park; Dae-Seong Myung; Sung-Bum Cho; Wan-Sik Lee; Jin-Woong Kim; Hyung-Hoon Oh; Young-Eun Joo
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Comparison between the treatment area of electrode used for radiofrequency ablation of liver cancer focusing on 15G cooled-tip and CWT electrode.

Authors:  Hyun-Jin Kim; Hae-Kag Lee; Jae-Hwan Cho
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.